Evidence map›Paper›PMID 37916254›Full record

ArticleCureus2023

Clinical and Endoscopic Differences Between Patients With Barrett's Esophagus With and Without Dysplasia/Adenocarcinoma.

Francisco Valdovinos-Andraca, Isaac Bartnicki-Navarrete, Ambrosio R Bernal-Mendez, Rafael Rafael Barreto-Zuñiga, Adriana F Romano-Munive, Armando Gamboa-Domínguez, Javier Elizondo-Rivera, Daniel Briseño-García, Felix I Tellez-Ávila

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 71% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Francisco Valdovinos-AndracaEndoscopy, National Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico City, MEX.
Isaac Bartnicki-NavarreteEndoscopy, National Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico City, MEX.
Ambrosio R Bernal-MendezEndoscopy, National Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico City, MEX.
Rafael Rafael Barreto-ZuñigaEndoscopy, National Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico City, MEX.
Adriana F Romano-MuniveEndoscopy, National Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico City, MEX.
Armando Gamboa-DomínguezPathology, National Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico City, MEX.
Javier Elizondo-RiveraEndoscopy, National Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico City, MEX.
Daniel Briseño-GarcíaEndoscopy, National Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico City, MEX.
Felix I Tellez-ÁvilaGastroenterology and Hepatology, University of Arkansas for Medical Sciences, Little Rock, USA.
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBarrett's esophagus (BE) is the main precursor of esophageal adenocarcinoma (EAC). This study aimed to identify the risk factors associated with BE progression to dysplasia or EAC in a Latin population.

methodsThe study is a retrospective analysis of a single-center cohort of patients with BE, evaluated from 2002 to 2012.

resultsWe identified 420 patients with BE; 281 (66.9%) of them were men with a mean age of 57.2 ± 15.3 years. Among all BE patients evaluated, 81 (19.3%) had progression to some degree of dysplasia/EAC. The mean follow-up was 5.6 years. Multivariate analysis showed that age (OR = 1.03), cigarette smoking (OR = 3.05), long-segment BE (OR = 4.81), and a visible lesion on BE (OR = 6.94) were associated with progression to dysplasia/EAC.

conclusionIn Latin patients with BE, age, cigarette smoking, long-segment BE, and the presence of lesions were associated with the presence of dysplasia/EAC.

Indexed as

barrett's esophagusdysplasiaesophageal adenocarcinomamexicorisk factors

Identifiers

PMID37916254
PMCPMC10617646
OpenAlexW4387231717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.